Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by donmayneon Jun 01, 2021 4:06pm
68 Views
Post# 33304777

Nov 19, 2018 - Mar 5, 2019 or 3.5 months

Nov 19, 2018 - Mar 5, 2019 or 3.5 monthsOn November 19, 2018, competitive bidding by CMS threatened VMD. The market reacted by dropping the stock price by 50%.  It stayed low for Dec, Jan and Feb and finally recovered to the pre-drop price.  The price dropped precipitously (2 days) and took a long time to recover.

The recent threat is slightly different.  There is still a threat of competitive bidding but that uncertainty has a future timeline.  The gaslighting report of the OIG suggests a punitive recovery of $29 Million that VMD disputes.  This time, the price had already dropped due to the impact of the phantom share plan and has further dropped day after day.  We will see how long it will take to recover but the next news is the Q2 in August which is 2.5 months.  

The heavy volume today is notable.  


<< Previous
Bullboard Posts
Next >>